Skip to main content

Mirikizumab Disease Interactions

There are 3 disease interactions with mirikizumab.

Moderate

Mirikizumab-mrkz (applies to mirikizumab) active infection

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral

Mirikizumab may increase the risk of infection. Patients should be evaluated for active infection before and during treatment with mirikizumab, and administration should be avoided if infection is detected.

References

  1. (2023) "Product Information. Omvoh (mirikizumab)." Lilly, Eli and Company, 1.0
Moderate

Mirikizumab-mrkz (applies to mirikizumab) hepatic impairment and cirrhosis

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

Mirikizumab can cause increased levels of liver enzymes and bilirubin. The effect of moderate to severe hepatic impairment on the pharmacokinetics of mirikizumab has not been evaluated. Other treatment options should be considered in patients with evidence of liver cirrhosis.

References

  1. (2023) "Product Information. Omvoh (mirikizumab)." Lilly, Eli and Company, 1.0
Moderate

Mirikizumab-mrkz (applies to mirikizumab) Tuberculosis (TB)

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Tuberculosis -- Active, Tuberculosis -- Latent

Patients treated with mirikizumab may be at increased risk for tuberculosis. Patients should be evaluated for TB before treatment with mirikizumab and therapy should be avoided in patients with active TB. Anti-TB therapy should be considered for patients with a history of latent or active TB.

References

  1. (2023) "Product Information. Omvoh (mirikizumab)." Lilly, Eli and Company, 1.0

Mirikizumab drug interactions

There are 193 drug interactions with mirikizumab.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer